With regard to AD, drugs that inhibit TNF signaling—such as anti-TNF antibodies (infliximab, for example), the immuno-suppressant rapamycin, and the immuno-modulator thalidomide—could be considered as potential therapies for the disease. Here, TNF is linked to Alzheimer disease.